| [1] |
Khattab S，Mohsen IA，Aboul Foutouh I，et al.Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome Prospective cohort study[J].Gynecol Endocrinol，2011，27（10）：789-793.
|
| [2] |
Gilbert C，Valois M，Koren G.Pregnancy outcome after firsttrimester exposure to metformin：a meta-analysis[J].Fertil Steril，2006，86（3）：658-663.
|
| [3] |
Lautatzis ME，Goulis DG，Vrontakis M.Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome：a systematic review[J].Metabolism，2013，62（11）：1522-1534.
|
| [4] |
Hod M，Kapur A，Sacks DA，et al.The international federation of gynecology and obstetrics（FIGO）initiative on gestational diabetes mellitus：a pragmatic guide for diagnosis，management，and care[J].Int J Gynaecol Obstet，2015，131（Suppl 3）：S173-S211.
|
| [5] |
Crane J，McGowan B.The GLP-1 agonist，liraglutide，as a pharmacotherapy for obesity[J].Ther Adv Chronic Dis，2016，7（2）：92-107.
|
| [6] |
Fujishima Y，Maeda N，Inoue K，et al.Efficacy of liraglutide，a glucagon-like peptide-1 （GLP-1） analogue，on body weight，eating behavior，and glycemic control，in Japanese obese type 2 diabetes[J].Cardiovasc Diabetol，2012，11：107.
|
| [12] |
中华医学会妇产科学分会内分泌学组.多囊卵巢综合征的诊断和治疗专家共识[J].中华妇产科杂志，2008，43（7）：553-555.
|
| [13] |
中华医学会妇产科学分会产科学组，中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病诊治指南（2014）[J].中华妇产科杂志，2014，49（8）：561-569.
|
| [19] |
Han S，Middleton P，Shepherd E，et al.Different types of dietary advice for women with gestational diabetes mellitus[J].Cochrane Database Syst Rev，2017，2：CD009275.
|
| [7] |
Jensterle Sever M，Kocjan T，Pfeifer M，et al.A short-term combined treatment with liraglutide and metformin leads to significantweightlossinobesewomenwithpolycysticovarysyndrome and previous poor response to metformin[J].Eur J Endocrinol，2014，170（3）：451-459.
|
| [8] |
Jensterle M，Kravos NA，Pfeifer M，et al.A short-term liraglu-tide treatment leads to a significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome[J].Hormones （Athens），2015，14（1）：81-90.
|
| [9] |
Jensterle M，Goricar K，Janez A.Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome：randomized control study[J].Exp Ther Med，2016，11（4）：1194-1200.
|
| [10] |
Zhuo Z，Wang A，Yu H.Effect of metformin intervention duringpregnancyonthegestationaldiabetesmellitusinwomen with polycystic ovary syndrome：a systematic review and meta-analysis[J].J Diabetes Res，2014，2014：381231.
|
| [11] |
Tan X，Li S，Chang Y，et al.Effect of metformin treatment during pregnancy on women with PCOS：a systematic review and meta-analysis[J].Clin Invest Med，2016，39（4）：E120-E131.
|
| [14] |
Foghsgaard S，Vedtofte L，Mathiesen ER，et al.The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus：protocol for an investigator-initiated，randomised，place-bo-controlled，double-blinded，parallel intervention trial[J].BMJ Open，2013，3（10）：e003834.
|
| [15] |
Niromanesh S，Alavi A，Sharbaf FR，et al.Metformin compared with insulin in the management of gestational diabetes mellitus：a randomized clinical trial[J].Diabetes Res Clin Pract，2012，98（3）：422-429.
|
| [16] |
Glueck CJ，Wang P，Kobayashi S，et al.Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome[J].Fertil Steril，2002，77（3）：520-525.
|
| [17] |
Astrup A，Rossner S，Van Gaal L，et al.Effects of liraglutide in the treatment of obesity：a randomised，doubleblind，placebo-controlled study[J].Lancet，2009，374（9701）：1606-1616.
|
| [18] |
Astrup A，Carraro R，Finer N，et al.Safety，tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog，liraglutide[J].Int J Obes （Lond），2012，36（6）：843-854.
|
| [20] |
Brown J，Martis R，Hughes B，et al.Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes[J].Cochrane Database Syst Rev，2017，1：CD011967.
|
